MENU
MRSH
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

MRSH stock forecast, quote, news & analysis

Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
MRSH
Daily Signal:
Gain/Loss:
A.I.Advisor
Oct 16, 2026

Marsh & McLennan (MRSH) Stock Analysis: Risk Advisory Leader Rebounds on Accelerating Consulting Growth

Key Takeaways

  • MRSH shares rose roughly 6% over the trailing 30-day period, recovering from a September pullback after a strong third-quarter earnings report released on October 15, 2026.
  • Third-quarter revenue increased 8% to $6.9 billion, while adjusted earnings per share grew 10% year over year to $2.03.
  • Management Consulting revenue jumped 14% on strong demand for AI-related services, a key driver of investor enthusiasm.
  • The company raised its "Thrive" cost-savings target to $600 million, up from $400 million, signaling confidence in margin expansion.
  • Soft insurance-rate conditions and reinsurance weakness remain notable offsets, with global insurance rates down 5% in the quarter.

Current Market Snapshot

Marsh & McLennan Companies (NYSE: MRSH) is trading near $187 per share, having rebounded from a September decline that took the stock below $170. The recovery gained momentum in mid-October when the firm delivered third-quarter results that exceeded expectations, with shares jumping roughly 4.7% in a single session. As a diversified professional-services business spanning insurance brokerage, reinsurance, benefits, and consulting, the company is widely followed as a bellwether for corporate risk-management spending and global insurance pricing trends.

Marsh & McLennan (MRSH) Business Overview and Competitive Position

Marsh & McLennan is a global leader in risk, strategy, and people, operating through two primary segments: Risk and Insurance Services and Consulting. The firm's four core businesses—Marsh (insurance brokerage), Guy Carpenter (reinsurance), Mercer (health, wealth, and career consulting), and Oliver Wyman (management consulting)—each hold leading positions in their respective markets, serving clients in more than 130 countries.

The company's competitive strength lies in its scale, deep industry expertise, and diversified revenue base, which spans insurance placement, reinsurance broking, benefits administration, asset management, and strategy consulting. Notably, the firm completed a corporate rebranding to "Marsh" and adopted the MRSH ticker symbol effective January 14, 2026, consolidating its identity around its flagship brokerage brand. Investors follow the stock for its consistent organic growth, disciplined capital returns through dividends and buybacks, and resilient earnings profile across economic cycles.

Recent Developments Driving MRSH

The most significant recent catalyst was the company's third-quarter 2026 earnings release, which reported 8% revenue growth to $6.9 billion and a 10% year-over-year increase in adjusted EPS to $2.03. Management Consulting stood out with 14% underlying growth, reflecting strong demand for AI-related advisory services and successful execution of digital initiatives.

Investors also responded favorably to the increase in the company's Thrive cost-transformation savings target from $400 million to $600 million, alongside stated intentions to reinvest those savings into sales, technology, and capabilities. Share repurchases totaled $500 million in the quarter and $2 billion year to date, underscoring management's confidence in cash generation.

Offsetting these positives, reinsurance revenue declined 6% amid soft market conditions, and global insurance rates fell 5% during the quarter—with property rates down 10%—pressuring brokerage commissions. The company also recorded $144 million in litigation costs tied to Greensill, which weighed on notable items and overall profitability.

Trending AI Robots

For investors seeking a systematic approach to monitoring price action and trade signals, Tickeron's Trending AI Robots page highlights a curated selection of algorithmic trading bots. Tickeron offers hundreds of AI trading bots that collectively trade thousands of tickers, but only the top-performing and most relevant bots are featured in this section. These bots vary considerably in strategy, trading timeframe, and performance metrics, allowing users to explore approaches that range from short-term momentum to longer-horizon trend following. The page provides a convenient way to review currently popular automated strategies and identify bots aligned with different market conditions.

2026 Outlook and What Investors Should Watch

Looking ahead, several factors will shape MRSH's trajectory through the remainder of 2026. Management flagged that fiduciary interest income, which declined $9 million year over year in the third quarter, is expected to fall further in the fourth quarter. Reinsurance conditions and global insurance-rate trends—particularly property pricing—will remain important variables for brokerage revenue growth.

On the positive side, continued momentum in AI-related consulting demand, the expanded Thrive savings program, and a robust mergers-and-acquisitions pipeline (with $288 million deployed on acquisitions in the quarter) offer potential upside. Investors should monitor upcoming earnings guidance, the pace of share repurchases, integration of recent acquisitions, and any further developments in the Greensill litigation, alongside broader macroeconomic conditions affecting corporate insurance spending.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for MRSH with price predictions
Oct 21, 2026

Momentum Indicator for MRSH turns positive, indicating new upward trend

MRSH saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 47 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 54%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MRSH just turned positive on October 02, 2026. Looking at past instances where MRSH's MACD turned positive, the stock continued to rise in 27 of 50 cases over the following month. The odds of a continued upward trend are 54%.

MRSH moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MRSH crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 48%.

Following a +1.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRSH advanced for three days, in 160 of 338 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

MRSH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MRSH entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MRSH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.989) is normal, around the industry mean (2.582). P/E Ratio (23.211) is within average values for comparable stocks, (17.872). Projected Growth (PEG Ratio) (1.486) is also within normal values, averaging (8.322). Dividend Yield (0.021) settles around the average of (0.047) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (2.968).

A.I.Advisor
published Dividends

MRSH paid dividends on August 14, 2026

Marsh MRSH Stock Dividends
А dividend of $0.99 per share was paid with a record date of August 14, 2026, and an ex-dividend date of July 23, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 14.21B. The market cap for tickers in the group ranges from 3.03K to 90.94B. MRSH holds the highest valuation in this group at 90.94B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was 9%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 15%. XHG experienced the highest price growth at 91%, while ZBAO experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 55
SMR Rating: 70
Profit Risk Rating: 87
Seasonality Score: 12 (-100 ... +100)
Marsh & McLennan (MRSH) Stock Analysis: Risk Advisory Leader Rebounds on Accelerating Consulting Growth